Suppr超能文献

培养的肾小球上皮细胞中尿激酶的合成与结合

Urokinase synthesis and binding by glomerular epithelial cells in culture.

作者信息

Rondeau E, Ochi S, Lacave R, He C J, Medcalf R, Delarue F, Sraer J D

机构信息

INSERM, Unité 64, Hôpital Tenon, Paris, France.

出版信息

Kidney Int. 1989 Oct;36(4):593-600. doi: 10.1038/ki.1989.235.

Abstract

Fibrin deposits are frequently observed in the course of proliferative extracapillary glomerulonephritis and could be related to a defective local fibrinolysis. We studied human glomerular epithelial cells in culture which were found to release mainly a urokinase-type plasminogen activator (u-PA) identified on zymography by its molecular weight (53 kD), its plasminogen activator activity, and its neutralization by specific polyclonal anti-u-PA IgG. Trace amounts of tissue-type plasminogen activator (t-PA) complexed to a plasminogen activator inhibitor type 1 (PAI-1) were identified with specific antibodies. Specific binding sites were found at the surface of glomerular epithelial cells (kD: 2.10(-9) M), partially occupied by secreted u-PA. The spontaneous u-PA activity of the culture medium conditioned by glomerular epithelial cells was very low, suggesting that u-PA was released in its inactive single chain proenzyme form (SC-u-PA). After activation of SC-u-PA by plasmin, u-PA activity of the culture medium was found to increase in a time- and dose-dependent manner when cells were incubated with phorbol myristic acetate (PMA). This effect was inhibited by H7, a protein kinase C inhibitor. Stimulation of u-PA synthesis by PMA was also observed in two different epithelial tubular cell lines. LLC-PK1 and MDCK cells. However, 8 bromo cyclic AMP which increased u-PA release by LLC-PK1 cells was found to inhibit u-PA release by PMA-stimulated glomerular epithelial cells and MDCK cells. By Northern blot analysis we found that PMA induced an increase of u-PA mRNA level in glomerular epithelial cells and that cyclic AMP had an opposite effect.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在增殖性毛细血管外肾小球肾炎病程中常可见纤维蛋白沉积,这可能与局部纤维蛋白溶解功能缺陷有关。我们研究了培养的人肾小球上皮细胞,发现其主要释放一种尿激酶型纤溶酶原激活物(u-PA),通过其分子量(53kD)、纤溶酶原激活物活性以及被特异性多克隆抗u-PA IgG中和来在酶谱上鉴定。用特异性抗体鉴定出与1型纤溶酶原激活物抑制剂(PAI-1)复合的微量组织型纤溶酶原激活物(t-PA)。在肾小球上皮细胞表面发现了特异性结合位点(解离常数:2.10(-9)M),部分被分泌的u-PA占据。由肾小球上皮细胞条件培养的培养基的自发u-PA活性非常低,提示u-PA以无活性的单链酶原形式(SC-u-PA)释放。纤溶酶激活SC-u-PA后,当细胞与佛波酯肉豆蔻酸乙酸酯(PMA)孵育时,发现培养基的u-PA活性以时间和剂量依赖的方式增加。这种作用被蛋白激酶C抑制剂H7抑制。在两种不同的肾小管上皮细胞系LLC-PK1和MDCK细胞中也观察到PMA对u-PA合成的刺激作用。然而,发现增加LLC-PK1细胞u-PA释放的8-溴环磷酸腺苷可抑制PMA刺激的肾小球上皮细胞和MDCK细胞的u-PA释放。通过Northern印迹分析,我们发现PMA诱导肾小球上皮细胞中u-PA mRNA水平升高,而环磷酸腺苷则有相反作用。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验